Share: 
Eldepryl® (selegiline hydrochloride) is a Parkinson's disease medication. It belongs to a group of medications known as monoamine oxidase inhibitors (MAOIs). It is only approved for use in combination with carbidopa-levodopa medications (such as Sinemet®, Sinemet® CR, or Parcopa®). Eldepryl is specifically designed for people who are experiencing a reduced response to their carbidopa-levodopa therapy.
Parkinson's disease results from the loss of neurons in a region of the brain that controls movement. This creates a shortage of the neurotransmitter (brain-signaling chemical) known as dopamine, causing movement problems that are characteristic of Parkinson's disease. The exact cause of Parkinson's disease is not currently known.
Depending on the severity of a person's symptoms, Parkinson's disease treatment can include:
- Medications (see Medications for Parkinson's Disease)
- Lifestyle changes and support
- Surgery.
Other Articles in This eMedTV Presentation
eMedTV Links
Copyright © 2006-2013 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.
This site complies with the HONcode standard for trustworthy health information:
verify here.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.
This site complies with the HONcode standard for trustworthy health information:
verify here.